MO1046: The Selection of Renal Replacement Therapy for End-Stage Kidney Disease Patients by the Shared Decision-Making Method

K Sakai, O Oota, T Hisanaga, T Yada… - Nephrology Dialysis …, 2022 - academic.oup.com
Abstract BACKGROUND AND AIMS In Japan,> 97% of patients with end-stage kidney
disease (ESKD) select hemodialysis as a renal replacement therapy (RRT). Hemodialysis …
被引用次数：3 相关文章

MO1046 THE SELECTION OF RENAL REPLACEMENT THERAPY FOR END-STAGE KIDNEY DISEASE PATIENTS BY THE SHARED DECISION-MAKING METHOD

K Sakai, O Oota, T Hisanaga, T Yada, R Matsui… - scholar.archive.org
BACKGROUND AND AIMS: In Japan,> 97% of patients with end-stage kidney disease
(ESKD) select hemodialysis as a renal replacement therapy (RRT). Hemodialysis (HD) and …

MO1046: The Selection of Renal Replacement Therapy for End-Stage Kidney Disease Patients by the Shared Decision-Making Method

K Sakai, O Oota, T Hisanaga, T Yada… - Nephrology Dialysis …, 2022 - academic.oup.com
Abstract BACKGROUND AND AIMS In Japan,> 97% of patients with end-stage kidney
disease (ESKD) select hemodialysis as a renal replacement therapy (RRT). Hemodialysis …